Regulatory and Scientific Development

The Regulatory and Scientific Development team at Attralus Therapeutics is responsible for guiding the regulatory strategy and scientific rigor behind the development of transformative therapies for systemic amyloidosis. This team collaborates closely across disciplines to ensure compliance with regulatory standards, facilitates product development from laboratory to clinic, and engages with health authorities to advance therapeutic candidates effectively through the pipeline. Their expertise encompasses regulatory affairs, quality assurance, CMC (chemistry, manufacturing, and controls), toxicology, and analytical development, ensuring that Attralus's innovations meet the highest safety and efficacy standards.